Bioinformatics approach for the design of siRNAs against SARS-CoV-2

Danmark Nyheder Nyheder

Bioinformatics approach for the design of siRNAs against SARS-CoV-2
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Bioinformatics approach for the design of siRNAs against SARS-CoV-2 biorxivpreprint umontpellier RNA siRNA SARSCoV2 COVID19 coronavirus covid bioinformatics

By Dr. Sanchari Sinha Dutta, Ph.D.Dec 14 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the bioRxiv* preprint server, scientists have developed a set of siRNAs against severe acute respiratory syndrome coronavirus 2 using computational approaches. The siRNAs demonstrate high antiviral activity against SARS-CoV-2 and are able to recognize all available viral sequences.

In the current study, scientists have used bioinformatics approaches to design siRNAs against SARS-CoV-2. They have validated the antiviral activities of these siRNAs using ex vivo models of SARS-CoV-2-infected cultured cells. A total of eight siRNA candidates with minimal off-targets were generated in the study. The off-targets refer to endogenous mRNA sequences other than the targeted viral sequences. The siRNAs were predicted to target viral sequences that are conserved in more than 99.8% of viral variants.

Furthermore, scientists performed optimization procedures using viral sequences from publicly available databases to determine the variant coverage of candidate siRNAs. They analyzed more than 13,000,000 sequences and identified 12 distinct triplets of siRNAs that could recognize each of the sequenced variants.

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

NewsMedical /  🏆 19. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariantsStudy finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariantsStudy finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants medrxivpreprint uarizona VCU SARSCoV2 Omicron coronavirus covid COVID19 antibody
Læs mere »

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalenceDetection of unreported infections based on SARS-CoV-2 antibody seroprevalenceDetection of unreported infections based on SARS-CoV-2 antibody seroprevalence Antibody Coronavirus COVID SARSCoV2 LancetRH_Americ CDCgov QuestDX Labcorp
Læs mere »

What is the relation between COVID-19 vaccination and new POTS-related diagnoses?What is the relation between COVID-19 vaccination and new POTS-related diagnoses?What is the relation between COVID-19 vaccination and new POTS-related diagnoses? NatureCVR CedarsSinai BrighamWomens COVID19 coronavirus covid vaccination vaccine diagnosis cardiac cardiology coronavirus
Læs mere »

Study suggests persistent inflammatory response triggered by SARS-CoV-2 may be responsible for observed sequelae in PASC patientsStudy suggests persistent inflammatory response triggered by SARS-CoV-2 may be responsible for observed sequelae in PASC patientsStudy suggests persistent inflammatory response triggered by SARS-CoV-2 may be responsible for observed sequelae in PASC patients biorxivpreprint unidue ChariteBerlin SARSCoV2 inflammation inflammatory covid coronavirus COVID19
Læs mere »

Study indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occursStudy indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occursStudy indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occurs CIDJournal NIAIDNews FredNatLab SARSCoV2 infection vaccine vaccination mucosal
Læs mere »

Polymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodiesPolymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodiesPolymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodies ImmunityCP karolinskainst polymorphism gene genetics SARSCoV2 coronavirus covid antibody antibodies
Læs mere »



Render Time: 2025-03-17 04:19:05